Drugs / OJP-2028
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00553865 | Nov 2007 → Oct 2008 | essential hypertension | Jeil Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OJP-2028 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00553865 ↗ |